Form 4 for AVNT AVIENT CORP

Accepted 2026-01-22 00:00:00 ET · period of report 2026-01-20 · accession 0001122976-26-000029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-01-22	2026-01-20	AVNT	Moh Woon Keat	SVP, Pres CAI	M - OptEx	$24.98	+1,870	14.4K	+15%	+$46.7K
D	2026-01-22	2026-01-20	AVNT	Moh Woon Keat	SVP, Pres CAI	F - Tax	$35.62	-1,618	12.8K	-11%	-$57.6K
D	2026-01-22	2026-01-20	AVNT	Moh Woon Keat	SVP, Pres CAI	M - OptEx	$0.00	-1,870	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-01-20	M	A	1,870	$24.98	14,425	D	—	—	(F2) This amount reflects a reduction of 20 shares that were over-reported on the Reporting Person's last Form 4 (as determined by a reconciliation to the Reporting Person's records). (F1) Includes dividend equivalents earned with respect to the vested restricted stock units.
2	Common	Common Stock	2026-01-20	F	D	1,618	$35.62	12,807	D	—	—
3	Derivative	Stock Appreciation Rights	2026-01-20	M	D	1,870	$0.00	0	D	$24.98 · — to 2026-02-10	1,870 Common Stock	(F3) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.